- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HFD: 2-fluoro-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-a mine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
GTP.2: 16 residues within 4Å:- Chain A: Y.79, V.80, V.302, R.375, K.379
- Chain C: K.447
- Chain D: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Ligands: DTP.31, MG.44
19 PLIP interactions:6 interactions with chain A, 11 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: A:R.375, D:V.41, D:Q.66, D:R.69
- Salt bridges: A:K.301, A:R.375, A:K.379, A:K.379, D:K.40, D:K.40, D:K.40, D:D.61, C:K.447, C:K.447
- pi-Cation interactions: A:R.375
- Water bridges: D:K.40, D:K.40, D:D.61, D:Q.66
GTP.6: 16 residues within 4Å:- Chain A: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain B: K.447
- Chain D: Y.79, V.80, V.302, R.375, K.379
- Ligands: MG.5, DTP.18
15 PLIP interactions:4 interactions with chain D, 9 interactions with chain A, 2 interactions with chain B- Salt bridges: D:R.375, D:K.379, D:K.379, A:K.40, A:K.40, A:K.40, A:D.61, B:K.447, B:K.447
- pi-Cation interactions: D:R.375
- Hydrogen bonds: A:V.41, A:Q.66, A:R.69
- Water bridges: A:K.40, A:D.61
GTP.17: 17 residues within 4Å:- Chain B: Y.79, V.80, V.302, R.375, L.377, K.379
- Chain C: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain D: K.447
- Ligands: MG.32, DTP.45
17 PLIP interactions:2 interactions with chain D, 8 interactions with chain C, 7 interactions with chain B- Salt bridges: D:K.447, D:K.447, C:K.40, C:K.40, C:K.40, C:D.61, B:R.375, B:K.379, B:K.379
- Hydrogen bonds: C:V.41, C:Q.66, C:R.69, B:R.375
- Water bridges: C:K.40, B:K.379, B:K.379
- pi-Cation interactions: B:R.375
GTP.34: 17 residues within 4Å:- Chain A: K.447
- Chain B: K.40, V.41, I.42, I.60, D.61, Q.66, R.69, F.89
- Chain C: Y.79, V.80, V.302, R.375, L.377, K.379
- Ligands: DTP.3, MG.4
19 PLIP interactions:11 interactions with chain B, 4 interactions with chain A, 4 interactions with chain C- Hydrogen bonds: B:V.41, B:Q.66, B:R.69
- Water bridges: B:K.40, B:K.40, B:D.61, B:Q.66, A:K.447, A:K.447
- Salt bridges: B:K.40, B:K.40, B:K.40, B:D.61, A:K.447, A:K.447, C:R.375, C:K.379, C:K.379
- pi-Cation interactions: C:R.375
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
DTP.3: 19 residues within 4Å:- Chain A: R.257, F.261, R.276, K.278, N.282, K.447
- Chain B: V.41, I.42, N.43, H.49
- Chain C: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.4, GTP.34
21 PLIP interactions:7 interactions with chain C, 12 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: C:V.80, C:F.81
- Salt bridges: C:H.300, C:H.300, C:K.301, C:K.301, C:K.301, A:R.257, A:R.276, A:K.278, A:K.278, A:K.278, A:K.447
- Hydrogen bonds: A:R.257, A:N.282, A:N.282, B:N.43, B:N.43
- Water bridges: A:K.447
- pi-Cation interactions: A:R.257, A:R.257
DTP.18: 19 residues within 4Å:- Chain A: V.41, I.42, N.43, H.49
- Chain B: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Ligands: MG.5, GTP.6
25 PLIP interactions:7 interactions with chain D, 16 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: D:V.80, D:F.81
- Salt bridges: D:H.300, D:H.300, D:K.301, D:K.301, D:K.301, B:R.257, B:R.276, B:K.278, B:K.278, B:K.278, B:K.447
- Hydrogen bonds: B:R.257, B:N.282, B:N.282, A:N.43, A:N.43
- Water bridges: B:R.257, B:R.276, B:R.276, B:R.276, B:K.278
- pi-Cation interactions: B:R.257, B:R.257
DTP.31: 19 residues within 4Å:- Chain A: V.80, F.81, I.249, R.296, H.300, K.301, V.302
- Chain C: R.257, F.261, R.276, K.278, N.282, K.447
- Chain D: V.41, I.42, N.43, H.49
- Ligands: GTP.2, MG.44
20 PLIP interactions:7 interactions with chain A, 11 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: A:V.80, A:F.81
- Salt bridges: A:H.300, A:H.300, A:K.301, A:K.301, A:K.301, C:R.257, C:R.276, C:K.278, C:K.278, C:K.278, C:K.447
- Hydrogen bonds: C:R.257, C:N.282, C:N.282, D:N.43, D:N.43
- pi-Cation interactions: C:R.257, C:R.257
DTP.45: 18 residues within 4Å:- Chain B: V.80, F.81, I.249, R.296, H.300, K.301
- Chain C: V.41, I.42, N.43, H.49
- Chain D: R.257, F.261, R.276, K.278, N.282, K.447
- Ligands: GTP.17, MG.32
20 PLIP interactions:7 interactions with chain B, 11 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: B:V.80, B:F.81
- Salt bridges: B:H.300, B:H.300, B:K.301, B:K.301, B:K.301, D:R.257, D:R.276, D:K.278, D:K.278, D:K.278, D:K.447
- Hydrogen bonds: D:R.257, D:N.282, D:N.282, C:N.43, C:N.43
- pi-Cation interactions: D:R.257, D:R.257
- 9 x MG: MAGNESIUM ION(Non-covalent)
MG.4: 4 residues within 4Å:- Chain A: K.447
- Chain B: K.40
- Ligands: DTP.3, GTP.34
No protein-ligand interaction detected (PLIP)MG.5: 3 residues within 4Å:- Chain A: K.40
- Ligands: GTP.6, DTP.18
No protein-ligand interaction detected (PLIP)MG.14: 5 residues within 4Å:- Chain A: R.130, D.233, D.235, K.236
- Ligands: HFD.1
No protein-ligand interaction detected (PLIP)MG.25: 5 residues within 4Å:- Chain B: R.130, D.233, D.235, K.236
- Ligands: HFD.16
No protein-ligand interaction detected (PLIP)MG.32: 3 residues within 4Å:- Chain C: K.40
- Ligands: GTP.17, DTP.45
No protein-ligand interaction detected (PLIP)MG.38: 4 residues within 4Å:- Chain C: K.236, Y.239, R.290
- Ligands: HFD.33
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:Y.239
MG.44: 3 residues within 4Å:- Chain D: K.40
- Ligands: GTP.2, DTP.31
No protein-ligand interaction detected (PLIP)MG.53: 2 residues within 4Å:- Chain D: H.139
- Ligands: HFD.46
No protein-ligand interaction detected (PLIP)MG.54: 6 residues within 4Å:- Chain D: R.88, N.131, H.134, H.139, H.157
- Ligands: HFD.46
No protein-ligand interaction detected (PLIP)- 23 x NA: SODIUM ION(Non-functional Binders)
NA.7: 6 residues within 4Å:- Chain A: P.82, G.83, S.85
- Chain D: H.86, E.90, H.246
Ligand excluded by PLIPNA.8: 3 residues within 4Å:- Chain A: I.372, R.375
- Chain D: Q.66
Ligand excluded by PLIPNA.9: 4 residues within 4Å:- Chain A: Q.195, Y.222, V.225, S.226
Ligand excluded by PLIPNA.10: 3 residues within 4Å:- Chain A: H.47, Y.255, K.256
Ligand excluded by PLIPNA.11: 2 residues within 4Å:- Chain A: Q.371, Y.374
Ligand excluded by PLIPNA.12: 6 residues within 4Å:- Chain A: K.72, S.85, N.87
- Chain D: K.72, S.85, N.87
Ligand excluded by PLIPNA.13: 5 residues within 4Å:- Chain A: Y.445, C.446, A.449, R.452
- Chain C: V.510
Ligand excluded by PLIPNA.19: 7 residues within 4Å:- Chain B: S.92, G.127, L.128, C.129, R.130, N.131
- Ligands: NA.20
Ligand excluded by PLIPNA.20: 9 residues within 4Å:- Chain B: F.65, L.68, S.92, L.128, C.129, R.130, N.131, L.132
- Ligands: NA.19
Ligand excluded by PLIPNA.21: 6 residues within 4Å:- Chain B: P.82, G.83, S.85
- Chain C: H.86, E.90, H.246
Ligand excluded by PLIPNA.22: 3 residues within 4Å:- Chain B: I.372, R.375
- Chain C: Q.66
Ligand excluded by PLIPNA.23: 4 residues within 4Å:- Chain B: E.266, N.451, R.452, A.453
Ligand excluded by PLIPNA.24: 7 residues within 4Å:- Chain B: Q.463, L.464, L.465, E.467
- Chain D: P.466, E.467, K.468
Ligand excluded by PLIPNA.30: 3 residues within 4Å:- Chain B: Y.79, E.373
- Chain C: Y.70
Ligand excluded by PLIPNA.35: 3 residues within 4Å:- Chain B: Q.66
- Chain C: I.372, R.375
Ligand excluded by PLIPNA.36: 3 residues within 4Å:- Chain C: H.288, N.291, Y.431
Ligand excluded by PLIPNA.37: 4 residues within 4Å:- Chain C: R.276, D.277, C.446, K.447
Ligand excluded by PLIPNA.47: 4 residues within 4Å:- Chain D: Q.195, Y.222, V.225, S.226
Ligand excluded by PLIPNA.48: 3 residues within 4Å:- Chain A: Q.66
- Chain D: I.372, R.375
Ligand excluded by PLIPNA.49: 6 residues within 4Å:- Chain B: R.296
- Chain D: N.252, F.253, N.282, D.285, M.286
Ligand excluded by PLIPNA.50: 5 residues within 4Å:- Chain D: Y.298, G.303, N.304, D.307
- Ligands: HFD.46
Ligand excluded by PLIPNA.51: 3 residues within 4Å:- Chain D: V.162, E.166, K.193
Ligand excluded by PLIPNA.52: 4 residues within 4Å:- Chain D: R.290, N.291, D.430
- Ligands: GLY.55
Ligand excluded by PLIP- 12 x GLY: GLYCINE(Non-covalent)(Non-functional Binders)
GLY.15: 6 residues within 4Å:- Chain A: R.290, H.294, Q.299, N.428, M.429, D.430
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.290, A:R.290, A:Q.299, A:D.430, A:D.430
- Salt bridges: A:R.290, A:H.294
GLY.26: 6 residues within 4Å:- Chain B: S.116, R.118, D.119, R.214, P.215, K.218
7 PLIP interactions:2 Ligand-Ligand interactions, 5 interactions with chain B- Hydrogen bonds: G.26, G.26, B:S.116, B:R.214
- Salt bridges: B:R.118, B:R.214, B:K.218
GLY.27: 4 residues within 4Å:- Chain B: R.229, R.272, H.441, R.455
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.229, B:R.272, B:R.455
- Salt bridges: B:R.272
GLY.39: 1 residues within 4Å:- Ligands: GLY.40
2 PLIP interactions:2 Ligand-Ligand interactions- Hydrogen bonds: G.40, G.40
GLY.40: 3 residues within 4Å:- Chain C: R.483, Y.487
- Ligands: GLY.39
2 PLIP interactions:2 Ligand-Ligand interactions- Hydrogen bonds: G.39, G.39
GLY.41: 2 residues within 4Å:- Chain C: Y.374, N.376
3 PLIP interactions:1 interactions with chain C, 2 Ligand-Ligand interactions- Hydrogen bonds: C:N.376, G.41, G.41
GLY.42: 5 residues within 4Å:- Chain C: R.290, H.294, N.428, M.429, D.430
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:R.290, C:D.430, C:D.430, C:D.430
- Salt bridges: C:R.290, C:H.294
GLY.43: 5 residues within 4Å:- Chain C: S.116, R.118, D.119, R.214, K.218
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:S.116, C:S.116
- Salt bridges: C:R.118, C:R.214, C:K.218
GLY.55: 7 residues within 4Å:- Chain D: R.290, H.294, Q.299, N.428, M.429, D.430
- Ligands: NA.52
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:R.290, D:R.290, D:Q.299, D:D.430, D:D.430
- Salt bridges: D:H.294
GLY.56: 2 residues within 4Å:- Chain D: G.248, Q.250
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:D.254
GLY.57: 0 residues within 4Å:- (No contacts)
1 PLIP interactions:1 interactions with chain D- Salt bridges: D:K.418
GLY.58: 4 residues within 4Å:- Chain D: V.411, L.412, Y.487, L.514
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:L.412, D:L.412
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.28: 4 residues within 4Å:- Chain B: K.363, R.366, E.367, K.370
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.366, B:E.367
TRS.29: 5 residues within 4Å:- Chain B: L.412, D.414, R.483, K.484, Y.487
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:D.414, B:D.414, B:R.483, B:R.483, B:Y.487
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x HFD: 2-fluoro-9-{5-O-[(R)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-arabinofuranosyl}-9H-purin-6-a mine(Non-covalent)
- 4 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 4 x DTP: 2'-DEOXYADENOSINE 5'-TRIPHOSPHATE(Non-covalent)
- 9 x MG: MAGNESIUM ION(Non-covalent)
- 23 x NA: SODIUM ION(Non-functional Binders)
- 12 x GLY: GLYCINE(Non-covalent)(Non-functional Binders)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 1 x PO4: PHOSPHATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Knecht, K.M. et al., The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-10-10
- Peptides
- Deoxynucleoside triphosphate triphosphohydrolase SAMHD1: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D